US
Insider
Ugur Sahin
Chief Executive OfficerUgur Sahin (Chief Executive Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in BioNTech SE (BNTX). The largest single filing was $8.4M of BNTX (86,000 sh across 2 lots, as filed), executed Sep 11.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$36.5M
shares × price, as filed
Last traded
Sep 18
Filed Sep 18
Median ADV $119.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $36.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 12 months
Most traded names
BNTX
BioNTech SE
BNTX · 0 buys · 6 sells
6 filings
Recent filings
BNTXSALE
BioNTech SE
View filing →
$6.2M64,000 sh across 2 lots
Exec Sep 17
Filed Sep 18 · 4:41 PM ET BNTXSALE BioNTech SE View filing → $4.7M
49,000 sh across 2 lots
Exec Sep 15
Filed Sep 16 · 4:46 PM ET BNTXSALE BioNTech SE View filing → $8.4M
86,000 sh across 2 lots
Exec Sep 11
Filed Sep 14 · 4:50 PM ET BNTXSALE BioNTech SE View filing → $2.0M
20,500 sh × $96.31
Exec Sep 10
Filed Sep 11 · 5:18 PM ET BNTXSALE BioNTech SE View filing → $7.2M
73,000 sh across 2 lots
Exec Sep 8
Filed Sep 9 · 5:29 PM ET BNTXSALE BioNTech SE View filing → $7.9M
76,500 sh across 2 lots
Exec Sep 3
Filed Sep 8 · 4:10 PM ET